Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The most recent EPS for Medtronic PLC is $1.36, beating expectations of $1.34.
How did Medtronic PLC MDT's revenue perform in the last quarter?
Medtronic PLC revenue for the last quarter is $1.36
What is the revenue estimate for Medtronic PLC?
According to 27 of Wall street analyst, the revenue estimate of Medtronic PLC range from $9.49B to $8.68B
What's the earning quality score for Medtronic PLC?
Medtronic PLC has a earning quality score of A-/70.69126. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Medtronic PLC report earnings?
Medtronic PLC next earnings report is expected in 2026-05-18
What are Medtronic PLC's expected earnings?
Medtronic PLC expected earnings is $8.99B, according to wall-street analysts.
Did Medtronic PLC beat earnings expectations?
Medtronic PLC recent earnings of $9.01B beat expectations.